Length variation in human genomic tandem repeats determines cell-specific gene regulation and complex trait variance
Background
Human genome research has focused on identifying single nucleotide polymorphisms (SNPs) over the past decades. While Genome-Wide Association Studies (GWAS) have identified numerous disease-associated loci, a significant portion of the mechanism by which genetic predisposition manifests as actual disease remains unknown. The academic community refers to this as 'missing heritability' and has investigated its causes from various angles.
A representative area that has been overlooked due to the limitations of existing analysis technologies is tandem repeats (TR). Tandem repeats are regions in which short nucleotide sequences are arranged consecutively, distributed widely across the genome. Because the sequences themselves repeat, it was difficult to accurately measure changes in the length of repeat units using past short-read sequencing techniques. In most variant studies, this region was often excluded as technical noise that causes analysis errors.
Gene expression analysis methods that were limited to the tissue level also posed a limitation. This is because it is difficult to capture subtle transcriptional regulation changes occurring in specific immune cells or rare cell populations when individual cells performing different functions are mixed. To reveal the mechanisms of complex diseases, a new approach that organically connects structural variations in the genome with molecular phenotypes at the individual cell level was urgently needed.
Key Findings
Researchers demonstrated at a genome-wide scale the impact of tandem repeat length variation on human cell gene expression by combining high-depth whole-genome sequencing (WGS) data with single-cell transcriptome analysis techniques. The research team employed a strategy of precisely profiling the diversity of tandem repeat lengths appearing in human cell groups and directly comparing them with cell-type-specific gene expression measurements.
As a result of the analysis, the difference in the unit length of tandem repeats appeared as a key factor inducing cell-type-specific expression disparities by interacting with adjacent regulatory regions. Unlike SNPs, which involve the substitution of a single base, physical structural changes resulting from the expansion or contraction of repeat units altered transcription factor binding affinity or locally regulated chromatin accessibility. It was revealed that even with the same tandem repeat length variation, different regulatory effects are induced depending on the immune cell type, such as B cells or T cells.
Tandem repeat length variation also directly contributed to the formation of the genetic architecture of complex traits. Integrating tandem repeat length variation into existing SNP-based analysis models significantly enhanced the genetic explanatory power when explaining susceptibility to multifactorial diseases, including immune disorders. This demonstrates that beyond simple sequence differences, the physical repeat count within the genome acts as a powerful epigenetic and transcriptional regulatory switch that shapes the unique identity of cells and their disease vulnerability.
Significance and Outlook
This study represents a significant achievement in expanding the scope of the human genome map, which had been biased toward single-nucleotide variants, to include polymorphic repeat regions. By elucidating at the molecular level how structural variations induce cell-specific regulatory abnormalities in non-coding regions, it is expected to invigorate research into the pathogenesis of complex diseases.
A foundation has been laid to improve the precision of algorithms for predicting personalized risk in diseases with significant inter-individual symptom variability, such as autoimmune or chronic inflammatory diseases. Identifying repeat sequence targets that cause abnormal gene overexpression specifically in certain immune cells could provide new regulatory targets for consideration during the development of precision therapeutics.
Challenges remain to be solved before generalizing to clinical practice. To precisely decode complex repeat regions, long-read sequencing technology must become widespread and be accompanied by reduced testing costs. Subsequent research to establish a standard reference database defining the typical length of tandem repeats across diverse ethnic groups worldwide is necessary to ensure clinical validity.
Nature, Published online: 28 October 2026; doi:10.1038/s41586-026-10438-2Whole-genome sequencing and cell-level gene expression measurements show that length variation in tandem repeats in the human genome contributes to cell type-specific differences in gene regulation and expression, as well as the architecture of complex traits.
This research provides practical tools to advance the precision molecular diagnosis and drug target discovery systems for complex immune diseases. For patients with autoimmune diseases such as rheumatoid arthritis and multiple sclerosis, in whom the cause could not be identified through existing gene panel tests, performing tandem repeat length measurement alongside testing can more precisely stratify individual disease risk and immune cell reactivity.
Drug development companies can diversify their research pipelines by discovering antisense oligonucleotides (ASOs) and small molecules that block or regulate transcription factor binding hyperactivated due to abnormal repeat sequence lengths. Practical application scenarios are also expected, such as using tandem repeat length as a selection criterion to evaluate the stability and function of specific immune cells in the manufacturing process of cell therapies.